Figure 6From: Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical developmentDistribution of proportion cured within the EC50 and k 1 deciles derived from the 5000 parameter sets for the anti-malarial combination therapy, artemether (ART) and lumefantrine (LM). Top panels are for artemether (EC50 – left hand side, kmax right hand side) and bottom panels are for lumefantrine (EC50 – left hand side, kmax right hand side).Back to article page